Logan Capital Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Logan Capital Management's DGX Position: Q3 2026 in Review
Logan Capital Management held its Quest Diagnostics (DGX) position steady in Q3 2026 at 5 shares worth $1.16K. The position accounts for ﹤0.01% of the portfolio, ranked #422.
Logan Capital Management first reported a position in DGX in Q2 2013 and has held it in 22 quarters since. The position peaked at $277K in Q1 2015. 1,142 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Logan Capital Management held 5 shares of Quest Diagnostics worth $1.16K as of Q3 2026.
- Logan Capital Management left its Quest Diagnostics share count unchanged in Q3 2026.
- Quest Diagnostics made up ﹤0.01% of Logan Capital Management's portfolio in Q3 2026, its #422 holding.
- Logan Capital Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 22 quarters since.
- Logan Capital Management's Quest Diagnostics position peaked at $277K in Q1 2015.
- 1,142 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Logan Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.